Kestra Medical Technologies (NASDAQ:KMTS) Stock: Insider Timothy Moran Sells 3,192 Shares

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) insider Timothy Moran sold 3,192 shares of the stock in a transaction on Tuesday, November 3rd. The stock was sold at an average price of $29.56, for a total value of $94,355.52. Following the transaction, the insider directly owned 63,153 shares in the company, valued at $1,866,802.68. The trade was a 4.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Kestra Medical Technologies Trading Up 0.9%

Shares of NASDAQ KMTS opened at $28.80 on Friday. The company has a current ratio of 4.69, a quick ratio of 4.69 and a debt-to-equity ratio of 0.33. Kestra Medical Technologies, Ltd. has a twelve month low of $17.34 and a twelve month high of $31.91. The stock has a 50 day moving average of $26.96 and a two-hundred day moving average of $23.99.

Kestra Medical Technologies (NASDAQ:KMTS) last released its earnings results on Monday, September 14th. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.61) by ($0.14). The business had revenue of $30.97 million for the quarter. Kestra Medical Technologies had a negative net margin of 140.43% and a negative return on equity of 63.83%. On average, research analysts expect that Kestra Medical Technologies, Ltd. will post -2.45 EPS for the current fiscal year.

Hedge Funds Weigh In On Kestra Medical Technologies

Several hedge funds and other institutional investors have recently modified their holdings of the business. Sterling Capital Management LLC boosted its position in Kestra Medical Technologies by 834.0% during the third quarter. Sterling Capital Management LLC now owns 878 shares of the company’s stock worth $25,000 after acquiring an additional 784 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in Kestra Medical Technologies by 6.6% in the first quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company’s stock valued at $1,844,000 after acquiring an additional 5,731 shares during the last quarter. California State Teachers Retirement System grew its position in Kestra Medical Technologies by 39.2% in the 1st quarter. California State Teachers Retirement System now owns 27,835 shares of the company’s stock worth $555,000 after purchasing an additional 7,844 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in Kestra Medical Technologies during the 3rd quarter valued at approximately $353,000. Finally, Quantinno Capital Management LP purchased a new stake in shares of Kestra Medical Technologies in the 1st quarter worth $431,000.

Wall Street Analysts Forecast Growth

A number of research firms have commented on KMTS. Wolfe Research set a $30.00 target price on Kestra Medical Technologies in a research report on Wednesday, July 15th. Wall Street Zen raised shares of Kestra Medical Technologies from a “sell” rating to a “hold” rating in a report on Saturday, October 31st. BTIG Research reiterated a “buy” rating and issued a $32.00 target price on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Oppenheimer started coverage on shares of Kestra Medical Technologies in a research note on Tuesday, July 21st. They set a “market perform” rating for the company. Finally, Evercore initiated coverage on shares of Kestra Medical Technologies in a research note on Tuesday, October 20th. They set an “outperform” rating and a $34.00 price target on the stock. Five investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $29.00.

Kestra Medical Technologies Company Profile

Kestra Medical Technologies, Inc is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary.

The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital.